Glucotrack Inc (GCTK)

$1.21 -0.06 (-4.72%)
Market Cap 1.22M
Revenue (ttm) 0.00
Net Income (ttm) -22.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.19
Volume 77,800
Avg Vol 404,212
Day's Range N/A - N/A
Shares Out 1.01M
Stochastic %K 25%
Beta 0.33
Analysts Strong Buy
Price Target N/A

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 842 7715
Address:
301 Route 17 North, Suite 800, Rutherford, United States
race2zero
race2zero Mar. 16 at 4:36 PM
$GCTK market is really green today and then there’s this…:
0 · Reply
race2zero
race2zero Mar. 16 at 4:27 PM
$GCTK
0 · Reply
race2zero
race2zero Mar. 16 at 4:13 PM
$GCTK @FkDisManipulation ’s average is now $0.97 it’s truly amazing
1 · Reply
Mushroomhead
Mushroomhead Mar. 16 at 4:11 PM
$GCTK what a loser
0 · Reply
race2zero
race2zero Mar. 16 at 3:31 PM
$GCTK
0 · Reply
race2zero
race2zero Mar. 16 at 3:04 PM
$GCTK let’s keep dropping and banking
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 2:38 PM
$GCTK @race2zero How much money did you lose here midget?
0 · Reply
race2zero
race2zero Mar. 16 at 2:27 PM
$GCTK teach me more about how you get an average lower than the bid (1.13) when you bought at 1.25
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 1:58 PM
$GCTK @race2zero RobinHooders... Does NOT know current BID and ASK 😄
2 · Reply
race2zero
race2zero Mar. 16 at 1:49 PM
$GCTK bid is .02 away from 52 week low and you started position at $1.25 and your average is lower that .$1.13, please help me understand
1 · Reply
Latest News on GCTK
Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Mar 10, 2026, 8:01 AM EDT - 6 days ago

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Jan 29, 2026, 8:01 AM EST - 6 weeks ago

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Dec 30, 2025, 8:00 AM EST - 2 months ago

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 13, 2025, 4:05 PM EST - 4 months ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Glucotrack, Inc. Encourages Shareholders to Vote

Nov 3, 2025, 4:05 PM EST - 4 months ago

Glucotrack, Inc. Encourages Shareholders to Vote

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 29, 2025, 4:05 PM EDT - 4 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Glucotrack, Inc. Reminds Shareholders to Vote

Oct 28, 2025, 8:00 AM EDT - 4 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

Glucotrack to Participate in the Q3 Virtual Investor Summit

Sep 11, 2025, 8:00 AM EDT - 6 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 7 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Aug 6, 2025, 8:30 AM EDT - 7 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 31, 2025, 8:30 AM EDT - 8 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Glucotrack Announces Repurchase of Series A Warrants

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Glucotrack Announces Repurchase of Series A Warrants

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 10:40 AM EDT - 9 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 25, 2025, 8:30 AM EDT - 9 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 12, 2025, 9:05 AM EDT - 9 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 4, 2025, 8:30 AM EDT - 10 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025, 8:30 AM EDT - 10 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025, 8:30 AM EDT - 10 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 5:10 PM EDT - 10 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025, 8:01 AM EDT - 10 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 16, 2025, 8:00 AM EDT - 11 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Apr 3, 2025, 8:01 AM EDT - 1 year ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 26, 2025, 8:01 AM EST - 1 year ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 12:24 PM EST - 1 year ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Feb 4, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 29, 2025, 9:00 AM EST - 1 year ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces ISO 13485:2016 Certification

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack to Present at TechBio Showcase™ 2025

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

May 2, 2024, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 22, 2024, 2:10 PM EDT - 2 years ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 16, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Apr 2, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Mar 12, 2024, 9:30 AM EDT - 2 years ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 27, 2024, 8:30 AM EST - 2 years ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

race2zero
race2zero Mar. 16 at 4:36 PM
$GCTK market is really green today and then there’s this…:
0 · Reply
race2zero
race2zero Mar. 16 at 4:27 PM
$GCTK
0 · Reply
race2zero
race2zero Mar. 16 at 4:13 PM
$GCTK @FkDisManipulation ’s average is now $0.97 it’s truly amazing
1 · Reply
Mushroomhead
Mushroomhead Mar. 16 at 4:11 PM
$GCTK what a loser
0 · Reply
race2zero
race2zero Mar. 16 at 3:31 PM
$GCTK
0 · Reply
race2zero
race2zero Mar. 16 at 3:04 PM
$GCTK let’s keep dropping and banking
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 2:38 PM
$GCTK @race2zero How much money did you lose here midget?
0 · Reply
race2zero
race2zero Mar. 16 at 2:27 PM
$GCTK teach me more about how you get an average lower than the bid (1.13) when you bought at 1.25
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 1:58 PM
$GCTK @race2zero RobinHooders... Does NOT know current BID and ASK 😄
2 · Reply
race2zero
race2zero Mar. 16 at 1:49 PM
$GCTK bid is .02 away from 52 week low and you started position at $1.25 and your average is lower that .$1.13, please help me understand
1 · Reply
anonAlb
anonAlb Mar. 16 at 1:40 PM
$GCTK hold the line 🚨🚨🚨🚨
0 · Reply
race2zero
race2zero Mar. 16 at 1:39 PM
$GCTK 🤣🤣🤣🤣 at least you can average down
1 · Reply
race2zero
race2zero Mar. 16 at 1:34 PM
$GCTK good morning sunshine. RED sun rising!
0 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 8:04 AM
$GCTK @race2zero @Enzo4u Don't bet against the market twinks, thats how you lost money in first place. Since both of you RobinHooding at 9AM buy all shares Long as its going up for conference. Imagine witching frim sidelines unable to profit from obvious moves. There is difference between making uneducated posts with bearish sentiment since you lost money but unable to profit from downwards move due to lacking shorting capabilities.
0 · Reply
anonAlb
anonAlb Mar. 16 at 1:38 AM
$GCTK hope everyone is ready to blow this up this week😎
0 · Reply
anonAlb
anonAlb Mar. 16 at 1:37 AM
$ASBP $GCTK $VYGR $XAIR you know GCTK is my nr 1 💎🚀🚀🚀🚀 going all in 😎🚨🚨🚨🚨🚨
0 · Reply
FkDisManipulation
FkDisManipulation Mar. 16 at 1:10 AM
$GCTK 1.50 leading upto the conference. Easy money...
0 · Reply
MysticFortune
MysticFortune Mar. 16 at 12:22 AM
$IPM My top watch this week, has the look, the DD and and a low float that can be sent up on a rally. $SGN $GCTK $WORX
0 · Reply
SPARTANVI
SPARTANVI Mar. 15 at 9:16 PM
$GCTK Heavy shorted since RS Low floater Potential PR next week 1.50 break activates it Room to 3$+ Gctk will be my toop watch with catalyst ahead $AEHL lets see if 1.70s is the bottom here Potential reversal post rs 760k float Heavy manipulation here aswell Needs to hold 1.80 for reversal $CJMB Watching next week 2.20/2.40 key
1 · Reply
FkDisManipulation
FkDisManipulation Mar. 15 at 7:40 PM
$GCTK this money losing fgt still frantically spamming. If you can't handle lose you shouldn't be trading midgetFGT. Go invest in index fund thats something more of your low caliber.
0 · Reply
Kastila
Kastila Mar. 15 at 6:08 PM
$GCTK
0 · Reply
Enzo4u
Enzo4u Mar. 15 at 6:08 PM
$GCTK this is going below 1 next week mark this post
0 · Reply